Millennium Management Portfolio holdings
Millennium Management, founded in 1989 by Israel (Izzy) Englander and Ronald Shear and headquartered in New York City, is a global multi-strategy hedge fund managing over $71 billion in assets as of late 2024, employing a decentralized model with over 300 independent trading teams. Operating across equities, fixed income, commodities, currencies, and derivatives, the firm uses a mix of quantitative and fundamental strategies, providing its portfolio managers with capital, infrastructure, and autonomy to pursue diverse investment approaches while enforcing strict risk management. With more than 5,400 employees across offices in London, Hong Kong, Singapore, and beyond, Millennium has evolved from its initial $35 million seed capital—partly from the Belzberg family—into a titan of the hedge fund world, known for its ability to attract top talent and deliver consistent returns. Under Englander’s leadership as chairman and CEO, the firm remains a low-profile yet highly influential force in global finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$643M |
| 2 |
AT&T
T
|
+$311M |
| 3 |
State Street Technology Select Sector SPDR ETF
XLK
|
+$306M |
| 4 |
Microsoft
MSFT
|
+$292M |
| 5 |
Ametek
AME
|
+$215M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$887M |
| 2 |
Apple
AAPL
|
+$694M |
| 3 |
PRAH
PRA Health Sciences, Inc.
PRAH
|
+$616M |
| 4 |
Amazon
AMZN
|
+$596M |
| 5 |
Linde
LIN
|
+$531M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 7.39% |
| 2 | Financials | 6.67% |
| 3 | Healthcare | 6.18% |
| 4 | Industrials | 4.97% |
| 5 | Consumer Discretionary | 4.39% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3626
CALL
Avantor
AVTR
$9.25B
| $2.45M | ﹤0.01% |
60,000
+30,000
| +100% | +$1.17M |
|
3627
National Bank Holdings
NBHC
$1.92B
| $2.45M | ﹤0.01% |
60,617
-154,127
| -72% | -$5.63M |
|
|
HMCOU
3628
DELISTED
HumanCo Acquisition Corp. Unit
HMCOU
| $2.45M | ﹤0.01% |
239,800
| – | – |
|
3629
Beyond Air
XAIR
$4.56M
| $2.45M | ﹤0.01% |
551
-125
| -18% | -$453K |
|
3630
Vanguard Morningstar Growth ETF
VUG
$225B
| $2.45M | ﹤0.01% |
50,646
+22,362
| +79% | +$1.11M |
|
|
HOLI
3631
DELISTED
Hollsys Automation Technologies INTERNATIONAL, LTD. COMMON (British Virgin Island)
HOLI
| $2.45M | ﹤0.01% |
118,246
+86,261
| +270% | +$1.58M |
|
|
FUV
3632
DELISTED
Arcimoto, Inc. Common Stock
FUV
| $2.45M | ﹤0.01% |
10,702
+7,616
| +247% | +$2.07M |
|
3633
Enerpac Tool Group
EPAC
$1.85B
| $2.44M | ﹤0.01% |
117,660
+57,654
| +96% | +$1.44M |
|
3634
BayCom
BCML
$333M
| $2.44M | ﹤0.01% |
131,066
-54,954
| -30% | -$983K |
|
|
APTX
3635
DELISTED
Aptinyx Inc. Common Stock
APTX
| $2.44M | ﹤0.01% |
1,041,392
-86,320
| -8% | -$220K |
|
|
NARI
3636
PUT
DELISTED
Inari Medical, Inc. Common Stock
NARI
| $2.43M | ﹤0.01% |
30,000
+10,000
| +50% | +$840K |
|
3637
CALL
Blackrock
BLK
$175B
| $2.43M | ﹤0.01% |
2,900
+2,100
| +263% | +$1.88M |
|
|
CMA
3638
PUT
DELISTED
Comerica
CMA
| $2.43M | ﹤0.01% |
30,200
+25,800
| +586% | +$1.86M |
|
3639
Seer Inc
SEER
$123M
| $2.43M | ﹤0.01% |
70,353
+54,727
| +350% | +$1.88M |
|
3640
CNX Resources
CNX
$5.33B
| $2.43M | ﹤0.01% |
192,355
+81,901
| +74% | +$991K |
|
3641
B2Gold
BTG
$5.13B
| $2.43M | ﹤0.01% |
709,557
+616,871
| +666% | +$2.38M |
|
3642
Fennec Pharmaceuticals
FENC
$333M
| $2.43M | ﹤0.01% |
257,621
-147,151
| -36% | -$1.1M |
|
3643
iShares MSCI Indonesia ETF
EIDO
$484M
| $2.42M | ﹤0.01% |
111,638
-233,787
| -68% | -$4.85M |
|
3644
Barings BDC
BBDC
$881M
| $2.42M | ﹤0.01% |
219,471
-48,333
| -18% | -$521K |
|
3645
Corcept Therapeutics
CORT
$12.2B
| $2.42M | ﹤0.01% |
122,844
+13,618
| +12% | +$285K |
|
|
EVRI
3646
CALL
DELISTED
Everi Holdings
EVRI
| $2.42M | ﹤0.01% |
+100,000
| New | +$2.28M |
|
|
RAD
3647
CALL
DELISTED
Rite Aid Corporation
RAD
| $2.41M | ﹤0.01% |
170,000
+50,000
| +42% | +$787K |
|
3648
CALL
Baxter International
BAX
$14.5B
| $2.41M | ﹤0.01% |
30,000
-245,000
| -89% | -$19.4M |
|
3649
Northeast Bank
NBN
$1.13B
| $2.41M | ﹤0.01% |
71,463
-58,729
| -45% | -$1.88M |
|
3650
Watts Water Technologies
WTS
$11.7B
| $2.41M | ﹤0.01% |
14,329
-3,466
| -19% | -$555K |
|
Similar funds
Millennium Management's Q3 2021 Portfolio in Review
As of Q3 2021, Millennium Management held 7,698 positions worth $167B, up 2.3% from $163B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Millennium Management deployed $8.65B of net new capital in Q3 2021, opening 1,244 new positions and adding to 2,720 existing holdings. Its largest new stake was Sight Sciences: 1,577,092 shares worth $35.8M.
By sector, the portfolio is most concentrated in Technology at 7.4% of assets, down from 7.8% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Apple, an estimated $694M trimmed.
- Millennium Management's largest Q3 2021 buy was Sight Sciences: 1,577,092 shares worth $35.8M.
- Millennium Management added most to State Street SPDR S&P 500 ETF Trust in Q3 2021, an estimated $643M increase.
- Millennium Management's biggest Q3 2021 reduction was Apple, cutting an estimated $694M.
- Millennium Management fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $887M.
- Millennium Management's ten largest holdings make up 18% of its $167B portfolio in Q3 2021.
- Millennium Management opened 1,244 new positions and closed 981 in Q3 2021.
- Millennium Management's portfolio value rose 2.3% quarter-over-quarter to $167B.
Based on Millennium Management's 13F filing for Q3 2021, filed 15 Nov 2021.